- cafead Feb 03, 2022 at 12:12: AM
via Novartis AG NVS reported disappointing fourth-quarter 2021 results as the Sandoz business continues to affect its performance.
Core earnings (excluding one-time charges) of $1.40 per share missed the Zacks Consensus Estimate of $1.44 but increased from $1.34 reported in the year-ago quarter.
article source
Core earnings (excluding one-time charges) of $1.40 per share missed the Zacks Consensus Estimate of $1.44 but increased from $1.34 reported in the year-ago quarter.
article source